-
1
-
-
84855792427
-
Cancer statistics, 2012
-
Siegel R, Naishadham D, and Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin 62, 10-29.
-
(2012)
CA Cancer J Clin
, vol.62
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
80955181031
-
The Hedgehog's tale: Developing strategies for targeting cancer
-
Ng JM and Curran T (2011). The Hedgehog's tale: developing strategies for targeting cancer. Nat Rev Cancer 11, 493-501.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 493-501
-
-
Ng, J.M.1
Curran, T.2
-
3
-
-
79955460636
-
Notch signalling in solid tumours: A little bit of everything but not all the time
-
Ranganathan P, Weaver KL, and Capobianco AJ (2011). Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11, 338-351.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 338-351
-
-
Ranganathan, P.1
Weaver, K.L.2
Capobianco, A.J.3
-
4
-
-
77952896646
-
TGFβ signalling: A complex web in cancer progression
-
Ikushima H and Miyazono K (2010). TGFβ signalling: a complex web in cancer progression. Nat Rev Cancer 10, 415-424.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 415-424
-
-
Ikushima, H.1
Miyazono, K.2
-
5
-
-
77951568703
-
Phosphoinositide signalling in cancer: Beyond PI3K and PTEN
-
Bunney TD and Katan M (2010). Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer 10, 342-352.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 342-352
-
-
Bunney, T.D.1
Katan, M.2
-
6
-
-
75149170979
-
Fibroblast growth factor signalling: From development to cancer
-
Turner N and Grose R (2010). Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10, 116-129.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 116-129
-
-
Turner, N.1
Grose, R.2
-
7
-
-
56749184290
-
Insulin and insulin-like growth factor signalling in neoplasia
-
Pollak M (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8, 915-928.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 915-928
-
-
Pollak, M.1
-
8
-
-
42549164807
-
Wnt signalling and its impact on development and cancer
-
Klaus A and Birchmeier W (2008). Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8, 387-398.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 387-398
-
-
Klaus, A.1
Birchmeier, W.2
-
9
-
-
77953725367
-
Emerging roles of PDGF-D signaling pathway in tumor development and progression
-
Wang Z, Ahmad A, Li Y, Kong D, Azmi AS, Banerjee S, and Sarkar FH (2010). Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochim Biophys Acta 1806, 122-130.
-
(2010)
Biochim Biophys Acta
, vol.1806
, pp. 122-130
-
-
Wang, Z.1
Ahmad, A.2
Li, Y.3
Kong, D.4
Azmi, A.S.5
Banerjee, S.6
Sarkar, F.H.7
-
10
-
-
84856213846
-
The diverse and complex roles of NF-κB subunits in cancer
-
Perkins ND (2012). The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer 12, 121-132.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 121-132
-
-
Perkins, N.D.1
-
11
-
-
77955942384
-
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
-
Kolch W and Pitt A (2010). Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer 10, 618-629.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 618-629
-
-
Kolch, W.1
Pitt, A.2
-
12
-
-
67749117934
-
Signal integration by JNK and p38 MAPK pathways in cancer development
-
Wagner EF and Nebreda AR (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9, 537-549.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 537-549
-
-
Wagner, E.F.1
Nebreda, A.R.2
-
14
-
-
78650510609
-
mTOR: From growth signal integration to cancer, diabetes and ageing
-
Zoncu R, Efeyan A, and Sabatini DM (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21-35.
-
(2011)
Nat Rev Mol Cell Biol
, vol.12
, pp. 21-35
-
-
Zoncu, R.1
Efeyan, A.2
Sabatini, D.M.3
-
15
-
-
80155142474
-
Rapamycin passes the torch: A new generation of mTOR inhibitors
-
Benjamin D, Colombi M, Moroni C, and Hall MN (2011). Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov 10, 868-880.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 868-880
-
-
Benjamin, D.1
Colombi, M.2
Moroni, C.3
Hall, M.N.4
-
16
-
-
67349241955
-
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival
-
Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, Gray NS, and Sabatini DM (2009). DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873-886.
-
(2009)
Cell
, vol.137
, pp. 873-886
-
-
Peterson, T.R.1
Laplante, M.2
Thoreen, C.C.3
Sancak, Y.4
Kang, S.A.5
Kuehl, W.M.6
Gray, N.S.7
Sabatini, D.M.8
-
17
-
-
81855228182
-
mTOR generates an auto-amplification loop by triggering the βTrCP and CK1α-dependent degradation of DEPTOR
-
Duan S, Skaar JR, Kuchay S, Toschi A, Kanarek N, Ben-Neriah Y, and Pagano M (2011). mTOR generates an auto-amplification loop by triggering the βTrCP and CK1α-dependent degradation of DEPTOR. Mol Cell 44, 317-324.
-
(2011)
Mol Cell
, vol.44
, pp. 317-324
-
-
Duan, S.1
Skaar, J.R.2
Kuchay, S.3
Toschi, A.4
Kanarek, N.5
Ben-Neriah, Y.6
Pagano, M.7
-
18
-
-
81855181738
-
mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR
-
Gao D, Inuzuka H, Tan MK, Fukushima H, Locasale JW, Liu P, Wan L, Zhai B, Chin YR, Shaik S, et al. (2011). mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. Mol Cell 44, 290-303.
-
(2011)
Mol Cell
, vol.44
, pp. 290-303
-
-
Gao, D.1
Inuzuka, H.2
Tan, M.K.3
Fukushima, H.4
Locasale, J.W.5
Liu, P.6
Wan, L.7
Zhai, B.8
Chin, Y.R.9
Shaik, S.10
-
19
-
-
81855167585
-
DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy
-
Zhao Y, Xiong X, and Sun Y (2011). DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy. Mol Cell 44, 304-316.
-
(2011)
Mol Cell
, vol.44
, pp. 304-316
-
-
Zhao, Y.1
Xiong, X.2
Sun, Y.3
-
20
-
-
33747819801
-
mTOR and cancer: Insights into a complex relationship
-
Sabatini DM (2006). mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6, 729-734.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 729
-
-
Sabatini, D.M.1
-
21
-
-
54549089738
-
Hypoxia signalling through mTOR and the unfolded protein response in cancer
-
Wouters BG and Koritzinsky M (2008). Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8, 851-864.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 851-864
-
-
Wouters, B.G.1
Koritzinsky, M.2
-
22
-
-
78649348967
-
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress
-
Sengupta S, Peterson TR, and Sabatini DM (2010). Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40, 310-322.
-
(2010)
Mol Cell
, vol.40
, pp. 310-322
-
-
Sengupta, S.1
Peterson, T.R.2
Sabatini, D.M.3
-
24
-
-
40549123676
-
mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase
-
Ghosh P, Wu M, Zhang H, and Sun H (2008). mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase. Cell Cycle 7, 373-381.
-
(2008)
Cell Cycle
, vol.7
, pp. 373-381
-
-
Ghosh, P.1
Wu, M.2
Zhang, H.3
Sun, H.4
-
25
-
-
0242497228
-
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
-
Busino L, Donzelli M, Chiesa M, Guardavaccaro D, Ganoth D, Dorrello NV, Hershko A, Pagano M, and Draetta GF (2003). Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426, 87-91.
-
(2003)
Nature
, vol.426
, pp. 87-91
-
-
Busino, L.1
Donzelli, M.2
Chiesa, M.3
Guardavaccaro, D.4
Ganoth, D.5
Dorrello, N.V.6
Hershko, A.7
Pagano, M.8
Draetta, G.F.9
-
26
-
-
0347361537
-
SCFβ-TrCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase
-
Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ, and Harper JW (2003). SCFβ-TrCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 17, 3062-3074.
-
(2003)
Genes Dev
, vol.17
, pp. 3062-3074
-
-
Jin, J.1
Shirogane, T.2
Xu, L.3
Nalepa, G.4
Qin, J.5
Elledge, S.J.6
Harper, J.W.7
-
27
-
-
0033611567
-
The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin
-
Latres E, Chiaur DS, and Pagano M (1999). The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene 18, 849-854.
-
(1999)
Oncogene
, vol.18
, pp. 849-854
-
-
Latres, E.1
Chiaur, D.S.2
Pagano, M.3
-
28
-
-
0033068154
-
The SCFβ-TrCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro
-
Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, and Harper JW (1999). The SCFβ-TrCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev 13, 270-283.
-
(1999)
Genes Dev
, vol.13
, pp. 270-283
-
-
Winston, J.T.1
Strack, P.2
Beer-Romero, P.3
Chu, C.Y.4
Elledge, S.J.5
Harper, J.W.6
-
29
-
-
33845583328
-
SAG/ROC-SCF β-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection
-
Tan M, Gallegos JR, Gu Q, Huang Y, Li J, Jin Y, Lu H, and Sun Y (2006). SAG/ROC-SCF β-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection. Neoplasia 8, 1042-1054.
-
(2006)
Neoplasia
, vol.8
, pp. 1042-1054
-
-
Tan, M.1
Gallegos, J.R.2
Gu, Q.3
Huang, Y.4
Li, J.5
Jin, Y.6
Lu, H.7
Sun, Y.8
-
30
-
-
0038243172
-
Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo
-
Guardavaccaro D, Kudo Y, Boulaire J, Barchi M, Busino L, Donzelli M, Margottin-Goguet F, Jackson PK, Yamasaki L, and Pagano M (2003). Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev Cell 4, 799-812.
-
(2003)
Dev Cell
, vol.4
, pp. 799-812
-
-
Guardavaccaro, D.1
Kudo, Y.2
Boulaire, J.3
Barchi, M.4
Busino, L.5
Donzelli, M.6
Margottin-Goguet, F.7
Jackson, P.K.8
Yamasaki, L.9
Pagano, M.10
-
31
-
-
0037534899
-
Prophase destruction of Emi1 by the SCF(βTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase
-
Margottin-Goguet F, Hsu JY, Loktev A, Hsieh HM, Reimann JD, and Jackson PK (2003). Prophase destruction of Emi1 by the SCF(βTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev Cell 4, 813-826.
-
(2003)
Dev Cell
, vol.4
, pp. 813-826
-
-
Margottin-Goguet, F.1
Hsu, J.Y.2
Loktev, A.3
Hsieh, H.M.4
Reimann, J.D.5
Jackson, P.K.6
-
32
-
-
77955535107
-
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(β-TrCP) ubiquitin ligase
-
Inuzuka H, Tseng A, Gao D, Zhai B, Zhang Q, Shaik S, Wan L, Ang XL, Mock C, Yin H, et al. (2010). Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(β-TrCP) ubiquitin ligase. Cancer Cell 18, 147-159.
-
(2010)
Cancer Cell
, vol.18
, pp. 147-159
-
-
Inuzuka, H.1
Tseng, A.2
Gao, D.3
Zhai, B.4
Zhang, Q.5
Shaik, S.6
Wan, L.7
Ang, X.L.8
Mock, C.9
Yin, H.10
-
33
-
-
0034691673
-
SCF(β-TrCP) and phosphorylation dependent ubiquitination of IκBα catalyzed by Ubc3 and Ubc4
-
Strack P, Caligiuri M, Pelletier M, Boisclair M, Theodoras A, Beer-Romero P, Glass S, Parsons T, Copeland RA, Auger KR, et al. (2000). SCF(β-TrCP) and phosphorylation dependent ubiquitination of IκBα catalyzed by Ubc3 and Ubc4. Oncogene 19, 3529-3536.
-
(2000)
Oncogene
, vol.19
, pp. 3529-3536
-
-
Strack, P.1
Caligiuri, M.2
Pelletier, M.3
Boisclair, M.4
Theodoras, A.5
Beer-Romero, P.6
Glass, S.7
Parsons, T.8
Copeland, R.A.9
Auger, K.R.10
-
34
-
-
33750325725
-
S6K1 and βTrCP-mediated degradation of PDCD4 promotes protein translation and cell growth
-
Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, and Pagano M (2006). S6K1 and βTrCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467-471.
-
(2006)
Science
, vol.314
, pp. 467-471
-
-
Dorrello, N.V.1
Peschiaroli, A.2
Guardavaccaro, D.3
Colburn, N.H.4
Sherman, N.E.5
Pagano, M.6
-
35
-
-
77952952860
-
Role of CK1 in GSK3β-mediated phosphorylation and degradation of snail
-
Xu Y, Lee SH, Kim HS, Kim NH, Piao S, Park SH, Jung YS, Yook JI, Park BJ, and Ha NC (2010). Role of CK1 in GSK3β-mediated phosphorylation and degradation of snail. Oncogene 29, 3124-3133.
-
(2010)
Oncogene
, vol.29
, pp. 3124-3133
-
-
Xu, Y.1
Lee, S.H.2
Kim, H.S.3
Kim, N.H.4
Piao, S.5
Park, S.H.6
Jung, Y.S.7
Yook, J.I.8
Park, B.J.9
Ha, N.C.10
-
36
-
-
33749246225
-
Polo-like kinase-1 controls proteasomedependent degradation of Claspin during checkpoint recovery
-
Mamely I, van Vugt MA, Smits VA, Semple JI, Lemmens B, Perrakis A, Medema RH, and Freire R (2006). Polo-like kinase-1 controls proteasomedependent degradation of Claspin during checkpoint recovery. Curr Biol 16, 1950-1955.
-
(2006)
Curr Biol
, vol.16
, pp. 1950-1955
-
-
Mamely, I.1
van Vugt, M.A.2
Smits, V.A.3
Semple, J.I.4
Lemmens, B.5
Perrakis, A.6
Medema, R.H.7
Freire, R.8
-
37
-
-
41149130221
-
Control of chromosome stability by the β-TrCP-REST-Mad2 axis
-
Guardavaccaro D, Frescas D, Dorrello NV, Peschiaroli A, Multani AS, Cardozo T, Lasorella A, Iavarone A, Chang S, Hernando E, et al. (2008). Control of chromosome stability by the β-TrCP-REST-Mad2 axis. Nature 452, 365-369.
-
(2008)
Nature
, vol.452
, pp. 365-369
-
-
Guardavaccaro, D.1
Frescas, D.2
Dorrello, N.V.3
Peschiaroli, A.4
Multani, A.S.5
Cardozo, T.6
Lasorella, A.7
Iavarone, A.8
Chang, S.9
Hernando, E.10
-
38
-
-
41149119961
-
SCFβ-TrCP controls oncogenic transformation and neural differentiation through REST degradation
-
Westbrook TF, Hu G, Ang XL, Mulligan P, Pavlova NN, Liang A, Leng Y, Maehr R, Shi Y, Harper JW, et al. (2008). SCFβ-TrCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 452, 370-374.
-
(2008)
Nature
, vol.452
, pp. 370-374
-
-
Westbrook, T.F.1
Hu, G.2
Ang, X.L.3
Mulligan, P.4
Pavlova, N.N.5
Liang, A.6
Leng, Y.7
Maehr, R.8
Shi, Y.9
Harper, J.W.10
-
39
-
-
58149312710
-
βTrCP and Rsk1/2-mediated degradation of BimEL inhibits apoptosis
-
Dehan E, Bassermann F, Guardavaccaro D, Vasiliver-Shamis G, Cohen M, Lowes KN, Dustin M, Huang DC, Taunton J, and Pagano M (2009). βTrCP and Rsk1/2-mediated degradation of BimEL inhibits apoptosis. Mol Cell 33, 109-116.
-
(2009)
Mol Cell
, vol.33
, pp. 109-116
-
-
Dehan, E.1
Bassermann, F.2
Guardavaccaro, D.3
Vasiliver-Shamis, G.4
Cohen, M.5
Lowes, K.N.6
Dustin, M.7
Huang, D.C.8
Taunton, J.9
Pagano, M.10
-
40
-
-
1842428734
-
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFβ-TrCP
-
Watanabe N, Arai H, Nishihara Y, Taniguchi M, Hunter T, and Osada H (2004). M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFβ-TrCP. Proc Natl Acad Sci USA 101, 4419-4424.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 4419-4424
-
-
Watanabe, N.1
Arai, H.2
Nishihara, Y.3
Taniguchi, M.4
Hunter, T.5
Osada, H.6
-
41
-
-
44349122993
-
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: Tipping the scales of cancer
-
Frescas D and Pagano M (2008). Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nat Rev Cancer 8, 438-449.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 438-449
-
-
Frescas, D.1
Pagano, M.2
-
42
-
-
26444473237
-
The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development
-
Knippschild U, Wolff S, Giamas G, Brockschmidt C, Wittau M, Wurl PU, Eismann T, and Stoter M (2005). The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development. Onkologie 28, 508-514.
-
(2005)
Onkologie
, vol.28
, pp. 508-514
-
-
Knippschild, U.1
Wolff, S.2
Giamas, G.3
Brockschmidt, C.4
Wittau, M.5
Wurl, P.U.6
Eismann, T.7
Stoter, M.8
-
43
-
-
32644451364
-
CKI, there's more than one: Casein kinase I family members in Wnt and Hedgehog signaling
-
Price MA (2006). CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling. Genes Dev 20, 399-410.
-
(2006)
Genes Dev
, vol.20
, pp. 399-410
-
-
Price, M.A.1
-
44
-
-
0037155691
-
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
-
Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, and He X (2002). Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847.
-
(2002)
Cell
, vol.108
, pp. 837-847
-
-
Liu, C.1
Li, Y.2
Semenov, M.3
Han, C.4
Baeg, G.H.5
Tan, Y.6
Zhang, Z.7
Lin, X.8
He, X.9
-
45
-
-
22844432019
-
SCFβ-TrCP controls clock dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein
-
Shirogane T, Jin J, Ang XL, and Harper JW (2005). SCFβ-TrCP controls clock dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein. J Biol Chem 280, 26863-26872.
-
(2005)
J Biol Chem
, vol.280
, pp. 26863-26872
-
-
Shirogane, T.1
Jin, J.2
Ang, X.L.3
Harper, J.W.4
-
46
-
-
34250788809
-
AKT/PKB signaling: Navigating downstream
-
Manning BD and Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274.
-
(2007)
Cell
, vol.129
, pp. 1261-1274
-
-
Manning, B.D.1
Cantley, L.C.2
-
47
-
-
80053203115
-
The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma
-
Gera J and Lichtenstein A (2011). The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma. Leuk Lymphoma 52, 1857-1866.
-
(2011)
Leuk Lymphoma
, vol.52
, pp. 1857-1866
-
-
Gera, J.1
Lichtenstein, A.2
-
48
-
-
33947529520
-
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers
-
Chin SF, Wang Y, Thorne NP, Teschendorff AE, Pinder SE, Vias M, Naderi A, Roberts I, Barbosa-Morais NL, Garcia MJ, et al. (2007). Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene 26, 1959-1970.
-
(2007)
Oncogene
, vol.26
, pp. 1959-1970
-
-
Chin, S.F.1
Wang, Y.2
Thorne, N.P.3
Teschendorff, A.E.4
Pinder, S.E.5
Vias, M.6
Naderi, A.7
Roberts, I.8
Barbosa-Morais, N.L.9
Garcia, M.J.10
-
49
-
-
0037428669
-
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2
-
Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI, Wolf J, Adamowicz M, Barth TF, Lichter P, et al. (2003). Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 103, 489-495.
-
(2003)
Int J Cancer
, vol.103
, pp. 489-495
-
-
Joos, S.1
Granzow, M.2
Holtgreve-Grez, H.3
Siebert, R.4
Harder, L.5
Martin-Subero, J.I.6
Wolf, J.7
Adamowicz, M.8
Barth, T.F.9
Lichter, P.10
-
50
-
-
26944453121
-
Highresolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer
-
van Duin M, van Marion R, Vissers K, Watson JE, van Weerden WM, Schroder FH, Hop WC, van der Kwast TH, Collins C, and van Dekken H (2005). Highresolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 44, 438-449.
-
(2005)
Genes Chromosomes Cancer
, vol.44
, pp. 438-449
-
-
van Duin, M.1
van Marion, R.2
Vissers, K.3
Watson, J.E.4
van Weerden, W.M.5
Schroder, F.H.6
Hop, W.C.7
van der Kwast, T.H.8
Collins, C.9
van Dekken, H.10
-
51
-
-
19944430321
-
Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization
-
van Duin M, van Marion R, Watson JE, Paris PL, Lapuk A, Brown N, Oseroff VV, Albertson DG, Pinkel D, de Jong P, et al. (2005). Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization. Cytometry A 63, 10-19.
-
(2005)
Cytometry A
, vol.63
, pp. 10-19
-
-
van Duin, M.1
van Marion, R.2
Watson, J.E.3
Paris, P.L.4
Lapuk, A.5
Brown, N.6
Oseroff, V.V.7
Albertson, D.G.8
Pinkel, D.9
de Jong, P.10
-
52
-
-
79960411515
-
Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma
-
Pei L, Xie P, Zhou E, Yang Q, Luo Y, and Tang Z (2011). Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma. Mol Med Report 4, 817-823.
-
(2011)
Mol Med Report
, vol.4
, pp. 817-823
-
-
Pei, L.1
Xie, P.2
Zhou, E.3
Yang, Q.4
Luo, Y.5
Tang, Z.6
-
53
-
-
33645769276
-
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
-
Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B, Stewart JP, Zhan F, Khatry D, Protopopova M, et al. (2006). High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9, 313-325.
-
(2006)
Cancer Cell
, vol.9
, pp. 313-325
-
-
Carrasco, D.R.1
Tonon, G.2
Huang, Y.3
Zhang, Y.4
Sinha, R.5
Feng, B.6
Stewart, J.P.7
Zhan, F.8
Khatry, D.9
Protopopova, M.10
-
54
-
-
84858323029
-
Deptor knockdown enhances mTOR activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy
-
Kazi AA, Hong-Brown L, Lang SM, and Lang CH (2011). Deptor knockdown enhances mTOR activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy. Mol Med 17, 925-936.
-
(2011)
Mol Med
, vol.17
, pp. 925-936
-
-
Kazi, A.A.1
Hong-Brown, L.2
Lang, S.M.3
Lang, C.H.4
-
56
-
-
80053634368
-
The dynamic nature of autophagy in cancer
-
Kimmelman AC (2011). The dynamic nature of autophagy in cancer. Genes Dev 25, 1999-2010.
-
(2011)
Genes Dev
, vol.25
, pp. 1999-2010
-
-
Kimmelman, A.C.1
-
57
-
-
80051668850
-
The dual role of autophagy in cancer
-
Eskelinen EL (2011). The dual role of autophagy in cancer. Curr Opin Pharmacol 11, 294-300.
-
(2011)
Curr Opin Pharmacol
, vol.11
, pp. 294-300
-
-
Eskelinen, E.L.1
-
58
-
-
84861117321
-
Molecular mechanisms underlying the time-dependent autophagy and apoptosis induced by nutrient depletion in multiple myeloma: A pilot study
-
Liu Y, Chen Y, Wen L, and Cui G (2012). Molecular mechanisms underlying the time-dependent autophagy and apoptosis induced by nutrient depletion in multiple myeloma: a pilot study. J Huazhong Univ Sci Technolog Med Sci 32, 1-8.
-
(2012)
J Huazhong Univ Sci Technolog Med Sci
, vol.32
, pp. 1-8
-
-
Liu, Y.1
Chen, Y.2
Wen, L.3
Cui, G.4
-
59
-
-
84863230667
-
BMK1 kinase suppresses epithelialmesenchymal transition through the Akt/GSK3ss signaling pathway
-
Chen R, Yang Q, and Lee JD (2012). BMK1 kinase suppresses epithelialmesenchymal transition through the Akt/GSK3ss signaling pathway. Cancer Res 72, 1579-1587.
-
(2012)
Cancer Res
, vol.72
, pp. 1579-1587
-
-
Chen, R.1
Yang, Q.2
Lee, J.D.3
-
60
-
-
84856152266
-
Targeting MET in cancer: Rationale and progress
-
Gherardi E, Birchmeier W, Birchmeier C, and Vande Woude G (2012). Targeting MET in cancer: rationale and progress. Nat Rev Cancer 12, 89-103.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 89-103
-
-
Gherardi, E.1
Birchmeier, W.2
Birchmeier, C.3
Vande, W.G.4
-
61
-
-
78651108985
-
Pancreatic cancer: Understanding and overcoming chemoresistance
-
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, and Sarkar FH (2011). Pancreatic cancer: understanding and overcoming chemoresistance. Nat Rev Gastroenterol Hepatol 8, 27-33.
-
(2011)
Nat Rev Gastroenterol Hepatol
, vol.8
, pp. 27-33
-
-
Wang, Z.1
Li, Y.2
Ahmad, A.3
Banerjee, S.4
Azmi, A.S.5
Kong, D.6
Sarkar, F.H.7
-
62
-
-
77958524854
-
Differential expression of mTOR signalling components in drug resistance in ovarian cancer
-
Foster H, Coley HM, Goumenou A, Pados G, Harvey A, and Karteris E (2010). Differential expression of mTOR signalling components in drug resistance in ovarian cancer. Anticancer Res 30, 3529-3534.
-
(2010)
Anticancer Res
, vol.30
, pp. 3529-3534
-
-
Foster, H.1
Coley, H.M.2
Goumenou, A.3
Pados, G.4
Harvey, A.5
Karteris, E.6
-
63
-
-
77957969261
-
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
-
Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, and Sarkar FH (2010). Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat 13, 109-118.
-
(2010)
Drug Resist Updat
, vol.13
, pp. 109-118
-
-
Wang, Z.1
Li, Y.2
Ahmad, A.3
Azmi, A.S.4
Kong, D.5
Banerjee, S.6
Sarkar, F.H.7
-
64
-
-
78649240797
-
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma
-
Boyd KD, Walker BA, Wardell CP, Ross FM, Gregory WM, Davies FE, and Morgan GJ (2010). High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma. Leuk Lymphoma 51, 2126-2129.
-
(2010)
Leuk Lymphoma
, vol.51
, pp. 2126-2129
-
-
Boyd, K.D.1
Walker, B.A.2
Wardell, C.P.3
Ross, F.M.4
Gregory, W.M.5
Davies, F.E.6
Morgan, G.J.7
-
65
-
-
79960081833
-
Resveratrol inhibits mTOR signaling by targeting DEPTOR
-
Liu M and Liu F (2011). Resveratrol inhibits mTOR signaling by targeting DEPTOR. Commun Integr Biol 4, 382-384.
-
(2011)
Commun Integr Biol
, vol.4
, pp. 382-384
-
-
Liu, M.1
Liu, F.2
-
66
-
-
78449241484
-
Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR
-
Liu M, Wilk SA, Wang A, Zhou L, Wang RH, Ogawa W, Deng C, Dong LQ, and Liu F (2010). Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J Biol Chem 285, 36387-36394.
-
(2010)
J Biol Chem
, vol.285
, pp. 36387-36394
-
-
Liu, M.1
Wilk, S.A.2
Wang, A.3
Zhou, L.4
Wang, R.H.5
Ogawa, W.6
Deng, C.7
Dong, L.Q.8
Liu, F.9
|